Results 171 to 180 of about 1,525 (194)

Oncolytic senecavirus A in tumor immunotherapy: Mechanisms, progress, and future directions

Virology
Oncolytic virotherapy has emerged as a promising immunotherapy strategy against cancer. As the first picornavirus tested in humans for its oncolytic potential, Senecavirus A (SVA) possesses several advantageous features, including its small size, rapid replication, and ability to penetrate the vascular system of solid tumors, allowing for the specific ...
Xiaoya Zhao, Wenjie Li, Yuan Sun, Jingyun Ma   +3 more
openaire   +2 more sources

The first detection of Senecavirus A in pigs in Thailand, 2016

Transboundary and Emerging Diseases, 2017
We report the first detection of Senecavirus A (SVA) in nine of 12 (75%) pigs in Thailand in 2016. The full-length genome demonstrated that Thai SVA isolates were closely related to the first Canada strain (11-55910-3) than the recent strains causing outbreaks in Brazil, the United States and China in 2015-2016.
K. Saeng-chuto, P. Rodtian, G. Temeeyasen, M. Wegner, D. Nilubol   +4 more
openaire   +2 more sources

Senecavirus A nonstructural protein 3A Inhibits Ago2-mediated RNAi antiviral response

Veterinary Microbiology
Senecavirus A (SVA) can infect pigs of all ages and poses a significant risk to the swine industry. RNA interference (RNAi) is a conserved antiviral immune defense pathway in eukaryotes, and many viruses have been proven to encode viral proteins as viral RNAi suppressors (VSRs) to evade RNAi-mediated antiviral response.
Mengru Luo, Xingyi Xie, Dengkun Wang, Xuechen Li, Xianghui Ling, Wenju Yuan, Jiahao Cong, Huihui Huang, Yuhang Zhang, Zhengjie Kong, Bo Wan   +10 more
openaire   +2 more sources

Integrative oncology: Addressing the global challenges of cancer prevention and treatment

Ca-A Cancer Journal for Clinicians, 2022
Jun J Mao,, Msce, Lorenzo Cohen, Karen M Mustian   +2 more
exaly  

Senecavirus A in the environment of sow slaughter plants

AASV Annual Meeting, 2022
A. Buckley, K. Hoffman, K. Faaberg, N. Humphry, J. Korslund, K. Lager   +5 more
openaire   +1 more source

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Cynthia Morata-Tarifa, Joyce M Slingerland   +1 more
exaly  

Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma

Ca-A Cancer Journal for Clinicians, 2020
Aaron J Grossberg, William L Hwang, Anirban Maitra   +2 more
exaly  

Oral complications of cancer and cancer therapy

Ca-A Cancer Journal for Clinicians, 2012
Joel B Epstein, Rene-Jean Bensadoun, Andrei Barasch   +2 more
exaly  

The financial burden and distress of patients with cancer: Understanding and stepping‐up action on the financial toxicity of cancer treatment

Ca-A Cancer Journal for Clinicians, 2018
Pricivel M Carrera, Hagop M Kantarjian, Victoria S Blinder   +2 more
exaly  

American Cancer Society Head and Neck Cancer Survivorship Care Guideline

Ca-A Cancer Journal for Clinicians, 2016
Nader Sadeghi, Katherine A Hutcheson, Gary H Lyman   +2 more
exaly